Saturday, March 07, 2015 11:45:38 AM
There are not too many Start-up Bio-Tech companies out there with a positive cash flow...
Regenicin's latest technology, which has been improved over the original IP will set the Bar for Regenerative Medicine..
Only the Copyright to the name was sold...
We won't call it Permaderm..
Recent RGIN News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 06:21:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM